Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell lines

Anti-Cancer Agents in Medicinal Chemistry

Volumn 14, Issue 2, 2014, Pages 313-318

  Karpel Massler, Georg ^a   Westhoff, Mike Andrew ^a   Kast, Richard E ^b   Dwucet, Annika ^a   Nonnenmacher, Lisa ^a   Wirtz, C Rainer ^a   Debatin, Klaus Michael ^a   Halatsch, Marc Eric ^a  

^a UNIVERSITY OF ULM   (Germany)

^b IIAIGC Headquarters   (United States)

Author keywords

Artesunate; Combination therapy; Cytostasis; Glioblastoma; Necrosis; Temozolomide

Indexed keywords

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARTEMISININS; CELL LINE, TUMOR; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM NEOPLASMS; DACARBAZINE; DRUG SYNERGISM; GLIOBLASTOMA; HUMANS; INHIBITORY CONCENTRATION 50; NECROSIS;

EID: 84893448747     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113136660340     Document Type: Article

References (26)

1. Stupp, R.; Mason, W. P.; Van Den Bent, M. J.; Weller, M.; Fisher, B.; Taphoorn, M. J.; Belanger, K.; Brandes, A. A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R. C.; Ludwin, S. K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J. G.; Eisenhauer, E.; Mirimanoff, R. O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 2005, 352, 987-996.
2. Klayman, D. L. Qinghaosu (artemisinin): an antimalarial drug from China. Science, 1985, 228, 1049-1055.
3. World Health Organization: Guidelines for the treatment of malaria, second edition, 1st revision. http://www. who. int/malaria/publications/atoz/9789241547925/en/index. html, 2011, Section 8. 4, pp. revised37-revised38.
4. Du, J. H.; Zhang, H. D.; Ma, Z. J.; Ji, K. M. Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemother. Pharmacol., 2010, 65, 895-902.
5. Efferth, T.; Dunstan, H.; Sauerbrey, A.; Miyachi, H.; Chitambar, C. R. The anti-malarial artesunate is also active against cancer. Int. J. Oncol., 2001, 18, 767-773.
6. Efferth, T.; Giaisi, M.; Merling, A.; Krammer, P. H.; Li-Weber, M. Artesunate induces ROS-mediated apoptosis in doxorubicinresistant T leukemia cells. PLoS One, 2007, 2, e693.
7. Hamacher-Brady, A.; Stein, H. A.; Turschner, S.; Toegel, I.; Mora, R.; Jennewein, N.; Efferth, T.; Eils, R.; Brady, N. R. Artesunate activates mitochondrial apoptosis in breast cancer cells via ironcatalyzed lysosomal reactive oxygen species production. J. Biol. Chem., 2011, 286, 6587-6601.
8. Li, L. N.; Zhang, H. D.; Yuan, S. J.; Tian, Z. Y.; Wang, L.; Sun, Z. X. Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway. Int. J. Cancer, 2007, 121, 1360-1365.
9. Rasheed, S. A.; Efferth, T.; Asangani, I. A.; Allgayer, H. First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int. J. Cancer, 2010, 127, 1475-1485.
10. Dell'Eva, R.; Pfeffer, U.; Vene, R.; Anfosso, L.; Forlani, A.; Albini, A.; Efferth, T. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem. Pharmacol., 2004, 68, 2359-2366.
11. Hou, J.; Wang, D.; Zhang, R.; Wang, H. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin. Cancer Res., 2008, 14, 5519-5530.
12. Lai, H.; Singh, N. P. Oral artemisinin prevents and delays the development of 7, 12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett., 2006, 231, 43-48.
13. Berger, T. G.; Dieckmann, D.; Efferth, T.; Schultz, E. S.; Funk, J. O.; Baur, A.; Schuler, G. Artesunate in the treatment of metastatic uveal melanoma-first experiences. Oncol. Rep., 2005, 14, 1599-1603.
14. Zhang, Z. Y.; Yu, S. Q.; Miao, L. Y.; Huang, X. Y.; Zhang, X. P.; Zhu, Y. P.; Xia, X. H.; Li, D. Q. Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao, 2008, 6, 134-138.
15. Efferth, T.; Ramirez, T.; Gebhart, E.; Halatsch, M. E. Combination treatment of glioblastoma multiforme cell lines with the antimalarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774. Biochem. Pharmacol., 2004, 67, 1689-1700.
16. Reichert, S.; Reinboldt, V.; Hehlgans, S.; Efferth, T.; Rödel, C.; Rödel, F. A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin. Radiother. Oncol., 2012, 103, 394-401.
17. Berman, P. A.; Adams, P. A. Artemisinin enhances heme-catalysed oxidation of lipid membranes. Free Radic. Biol. Med., 1997, 22, 1283-1288.
18. Li, P. C.; Lam, E.; Roos, W. P.; Zdzienicka, M. Z.; Kaina, B.; Efferth, T. Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res., 2008, 68, 4347-4351.
19. Meshnick, S. R.; Yang, Y. Z.; Lima, V.; Kuypers, F.; Kamchonwongpaisan, S.; Yuthavong, Y. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob. Agents Chemother., 1993, 37, 1108-1114.
20. Thanaketpaisarn, O.; Waiwut, P.; Sakurai, H.; Saiki, I. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-kappaB and PI3K/Akt signaling pathways. Int. J. Oncol., 2011, 39, 279-285.
21. Berdelle, N.; Nikolova, T.; Quiros, S.; Efferth, T.; Kaina, B. Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Mol. Cancer Ther., 2011, 10, 2224-2233.
22. Gdynia, G.; Grund, K.; Eckert, A.; Bock, B. C.; Funke, B.; Macher-Goeppinger, S.; Sieber, S.; Herold-Mende, C.; Wiestler, B.; Wiestler, O. D.; Roth, W. Basal caspase activity promotes migration and invasiveness in glioblastoma cells. Mol. Cancer Res., 2007, 5, 1232-1240.
23. Huang, Q.; Li, F.; Liu, X.; Li, W.; Shi, W.; Liu, F. F.; O'Sullivan, B.; He, Z.; Peng, Y.; Tan, A. C.; Zhou, L.; Shen, J.; Han, G.; Wang, X. J.; Thorburn, J.; Thorburn, A.; Jimeno, A.; Raben, D.; Bedford, J. S.; Li, C. Y. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat. Med., 2011, 17, 860-866.
24. Hien, T. T.; Phu, N. H.; Mai, N. T.; Chau, T. T.; Trang, T. T.; Loc, P. P.; Cuong, B. M.; Dung, N. T.; Vinh, H.; Waller, D. J. An open randomized comparison of intravenous and intramuscular artesunate in severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg., 1992, 86, 584-585.
25. Miller, R. S.; Li, Q.; Cantilena, L. R.; Leary, K. J.; Saviolakis, G. A.; Melendez, V.; Smith, B.; Weina, P. J. Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: Phase Ib study. Malar. J., 2012, 11, 255.
26. Davis, T. M. E.; Binh, T. Q.; Ilett, K. F.; Batty, K. T.; Phuöng, H. L.; Chiswell, G. M.; Phuong, V. D. B.; Agus, C. Penetration of dihydroartemisinin into cerebrospinal fluid after administration of intravenous artesunate in severe falciparum malaria. Antimicrob. Agents Chemother., 2003, 47, 368-370.